DIENOGEST VERSUS LEVONORGESTREL IUS ON DEEP ENDOMETRIOSIS PATIENT´S QUALITY OF LIFE WITHOUT SURGERY: A RANDOMIZED OPEN-LABEL CLINICAL TRIAL
Dienogest or LNG-IUS used as treatment for deep endometriosis symptoms are equally associated with improvement of perception of quality of life in patients with no prior surgical treatment.
Steps to reproduce
patients with no previous surgery, with clinical and image diagnosis of deep endoetriosis were divided into 2 groups, one received dienogest on oral route, and the other received a levonorgestrel intrauterine device. quality of life was assessed prior to treatment and 6 months after, using validated to portugese versions of SF36 and EHP30 questionaries.